Aggravated airway inflammation: research on genomics and optimal treatments

  • Toppila-Salmi, Sanna (Projektledare)
  • Kauppi, Paula (Deltagare)
  • Laulajainen-Hongisto, Anu (Deltagare)
  • Hammaren-Malmi, Sari (Ansvarig forskare)
  • Hafren, Lena (Deltagare)
  • Mäkelä, Mika (Deltagare)
  • Mäkitie, Antti (Deltagare)
  • Fokkens, Wytske (Deltagare)
  • Reitsma, Sietze (Deltagare)
  • Sillanpää, Saara (Deltagare)
  • Karjalainen, Jussi (Deltagare)
  • Sahlman, Johanna (Deltagare)
  • Kiviranta, Jukka (Deltagare)
  • Halme, Perttu (Deltagare)
  • Kilpeläinen, Maritta (Deltagare)
  • Alakärppä, Antti (Deltagare)
  • Tiitto, Leena (Deltagare)
  • Virkkula, Paula Maarit (Projektledare)

Beskrivning

This is a randomized controlled multicenter study that focuses on severe CRSwNP ± asthma ±AERD. The clinical significance of this study is to develop cost-effective treatment models that will facilitate risk-estimation and prevention of the onset and the progression of severe CRSwNP, asthma and AERD.
AkronymAirGOs-Oper, AirGOs-Medical
StatusPågående
Gällande start-/slutdatum01/05/2018 → …